Biohit
2.37 EUR
+1.72 %
4,934 following
BIOBV
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Dividend
Investor consensus
+1.72 %
-12.22 %
-4.44 %
-35.77 %
-28.83 %
-15.05 %
+30.22 %
+16.18 %
-54.42 %
Biohit operates in the medical technology sector. The company develops and manufactures laboratory equipment, consumables and diagnostic analysis systems adapted for research, healthcare and industrial laboratories. In addition to its main business, it offers technical support, maintenance and training services within the aforementioned field of work. The largest operations are conducted in the Nordic market. The company has its headquarters in Helsinki.
Read moreMarket cap
36.04M EUR
Turnover
22.62K EUR
P/E (adj.) (26e)
16.24
EV/EBIT (adj.) (26e)
10.81
P/B (26e)
2.09
EV/S (26e)
1.67
Dividend yield-% (26e)
1.85 %
Coverage
Analyst
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
3.6
2026
General meeting '26
5.8
2026
Interim report Q2'26
Risk
Business risk
Valuation risk
Low
High
All
Research
Press releases
ShowingAll content types
Notice of Biohit Oyj’s Annual General Meeting
Notice of Biohit Oyj’s Annual General Meeting
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
